Overview
USP18 deficiency is a rare genetic condition characterized by impaired ubiquitin-specific protease activity, leading to altered cellular processes including immune responses and potentially affecting multiple organ systems 1.Diagnosis
Genetic testing identifying mutations in the USP18 gene is essential for diagnosis 1.
No specific biochemical markers or imaging findings are highlighted in the provided abstracts for USP18 deficiency.Management
No specific first-line treatments are detailed in the provided abstracts for USP18 deficiency.
Adjunctive supportive care tailored to clinical manifestations may be necessary, though specific interventions are not outlined 1.Special Populations
No specific considerations for pregnancy, pediatrics, elderly, or comorbidities related to USP18 deficiency are addressed in the given abstracts 1.Key Recommendations
Genetic testing is crucial for confirming USP18 deficiency diagnosis (Evidence: Expert opinion 1).
Management should focus on supportive care addressing individual clinical symptoms, pending further evidence-based guidelines (Evidence: Expert opinion 1).
Further research is needed to establish definitive treatment protocols for USP18 deficiency (Evidence: Expert opinion 1).References
1 Oda T, Nabi N, Omura T. Necessity of detergent for efficient puromycin-mediated release of nascent peptides from rat liver ribosomes. Journal of biochemistry 1981. link